Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus zolpidem versus placebo for sleep quality and mental health in methadone-treated adults with substance abuse
IRCT20201214049718N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sleep disorder and substance use disorder (SUD) comparing Melatonin, Zolpidem and Placebo (3 arms). Primary endpoints: Sleep quality, Mental health and 2 more. Started Jan 2021; status: completed.
02
Drugs
melatoninzolpidem
03
Conditions
sleep disordersubstance use disorder (SUD)
Beyond the preview
Go deeper on IRCT20201214049718N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201214049718N1.